Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma
14/05/2021
/
Publications
/
Dosimetry
This study included148 chordoma and chondrosarcoma patients and 283 individual eyes with functional vision at baseline who received a minimum 30GyRBE to 0.1cm3...
Particle Radiotherapy for Skull Base Chondrosarcoma: A Clinical Series from Italian National Center for Oncological Hadrontherapy.
14/09/2021
/
Publications
/
Toxicity
This study reported outcomes of 48 patients with skull base chondrosarcoma who underwent particle therapy (67% PT, 33% CIRT). With a median follow-up of 38...
Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience.
14/03/2023
/
Publications
/
Toxicity
This study reported clinical outcomes of 44 patients treated with proton (89%) or carbon ion therapy (11%). At a median follow-up of 34.3 months, 2-, and 3-year...
Proton versus photon radiation therapy: A clinical review.
16/03/2023
/
Publications
/
Clinical Trial
This review summarized comparative clinical outcomes between proton and photon radiotherapy. 63 interventional comparative studies were presented in this...
Proton Reirradiation for Locoregionally Recurrent Breast Cancer
08/05/2021
/
Publications
/
Reirradiation
A study by UPenn and Sloan Kettering. This study reviewed outcomes of the 27 patients with a history of prior radiation and treated with proton therapy for...
Proton therapy for non-small cell lung cancer: the road ahead.
11/09/2019
/
Publications
This latest review article examined the up-to-date clinical data of PBT for both early stage and locally advanced stage NSCLC. In particular, this review...
Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer.
11/10/2019
/
Publications
/
Reirradiation
This retrospective study analyzing 16 patients with locally recurrent breast cancer who underwent re-irradiation to the chest wall with PBT to the median dose...
Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast Cancer
10/10/2019
/
Publications
Published by the Jacksonville group, this study set to determine factors that influence insurance approval for breast cancer patients for whom adjuvant proton...
A population-based assessment of proton beam therapy utilization in California.
01/02/2020
/
Publications
Based on data from California Cancer Registry, this study reported that of the 2,499,510 people with a cancer diagnosis during the study period, 578,632 (23%)...
End-of-Range Radiobiological Effect on Rib Fractures in Patients Receiving Proton Therapy for Breast Cancer.
03/03/2020
/
Publications
Published in the Red Journal, this MGH study looked into the possible causes to the high rate of rib fracture that reported in the recent MGH prospective trial...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.